Archit organosys Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate, dated April 13, 2026, covers the quarter ended March 31, 2026, and demonstrates the company's adherence to mandatory depositories compliance procedures.

Regulatory Compliance Details

The certificate was filed under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting by listed companies regarding their dematerialisation processes. The submission was made by Chairman & Whole time Director Kandarp K. Amin (DIN: 00038972) to BSE Limited at Phiroze Jeejeebhoy Towers, Mumbai.

Registrar Confirmation

MUFG Intime India Private Limited (formerly Link Intime India Private Limited), serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate on April 1, 2026. The registrar confirmed compliance with all dematerialisation requirements during the quarter ended March 31, 2026.

The registrar's certificate, signed by Sr. Vice President-Corporate Registry Ashok Shetty, confirms several key compliance aspects:

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All security certificates were appropriately accepted or rejected within prescribed timelines
• Received certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• Securities comprised in certificates have been listed on relevant stock exchanges

Company Information

Archit Organosys Limited operates from its registered office at 903, 9th Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, Ahmedabad-380054, Gujarat. The company holds CIN: L24110GJ1993PLC019941 and maintains its operational facility at 25/9/A, Phase III, G.I.D.C., Naroada, Ahmedabad.

Regulatory Framework

The SEBI (Depositories and Participants) Regulations, 2018 require listed companies to file quarterly certificates confirming proper handling of dematerialisation processes. This regulatory framework ensures transparency in securities handling and maintains investor confidence in the depository system. The quarterly filing demonstrates the company's commitment to regulatory compliance and proper governance practices.

Suchit K. Amin has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding his acquisition of equity shares in Archit Organosys Limited. The transaction was completed on March 19, 2026, through open market purchase.

Share Acquisition Details

The acquisition involved 4,263 equity shares, representing 0.02% of the company's total share capital. This transaction increased Amin's total shareholding in the company from his previous position.

Promoter Group Information

Suchit Kandarp Amin belongs to the promoter group of Archit Organosys Limited. The disclosure identifies several persons acting in concert (PAC) with the acquirer:

• Kandarp Amin
• Archana Amin
• Archit Amin
• Shimoli Amin
• Manini Amin

Company Share Capital Structure

The company's equity share capital structure remained unchanged following this transaction:

Transaction Specifics

The acquisition was executed through open market purchase on March 19, 2026. The disclosure confirms that no shares were encumbered, and no voting rights were acquired otherwise than by shares. Additionally, no warrants, convertible securities, or other instruments entitling the acquirer to receive shares carrying voting rights were involved in this transaction.

The filing indicates that the acquirer held no encumbrances such as pledges, liens, or non-disposal undertakings both before and after the acquisition. The total diluted share capital of the company remains at Rs. 20,52,07,230, consisting of 2,05,20,723 equity shares of Rs. 10 each.